A detailed history of Core First Bank & Trust transactions in Merck & Co., Inc. stock. As of the latest transaction made, Core First Bank & Trust holds 11,214 shares of MRK stock, worth $930,874. This represents 0.67% of its overall portfolio holdings.

Number of Shares
11,214
Previous 11,595 3.29%
Holding current value
$930,874
Previous $1.32 Million 15.27%
% of portfolio
0.67%
Previous 0.77%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$96.31 - $114.76 $36,694 - $43,723
-381 Reduced 3.29%
11,214 $1.12 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $20,055 - $21,539
-162 Reduced 1.38%
11,595 $1.44 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $57,412 - $66,898
-507 Reduced 4.13%
11,757 $1.55 Million
Q4 2023

Mar 18, 2024

SELL
$100.18 - $109.02 $26,547 - $28,890
-265 Reduced 2.12%
12,264 $1.34 Million
Q3 2023

Dec 18, 2023

SELL
$102.95 - $114.33 $2,367 - $2,629
-23 Reduced 0.18%
12,529 $1.29 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $91,341 - $99,557
-841 Reduced 6.28%
12,552 $1.45 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $96,145 - $107,279
-934 Reduced 6.52%
13,393 $1.42 Million
Q4 2022

Feb 15, 2023

SELL
$87.44 - $112.11 $3,147 - $4,035
-36 Reduced 0.25%
14,327 $1.59 Million
Q3 2022

Nov 16, 2022

SELL
$84.53 - $94.96 $40,743 - $45,770
-482 Reduced 3.25%
14,363 $1.24 Million
Q2 2022

Aug 16, 2022

BUY
$83.49 - $94.64 $85,493 - $96,911
1,024 Added 7.41%
14,845 $1.35 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $45,576 - $51,088
-620 Reduced 4.29%
13,821 $1.13 Million
Q4 2021

Feb 10, 2022

SELL
$72.28 - $90.54 $13,733 - $17,202
-190 Reduced 1.3%
14,441 $1.11 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $50,534 - $55,575
705 Added 5.06%
14,631 $1.1 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $999,469 - $1.11 Million
13,926 New
13,926 $1.14 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $210B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Core First Bank & Trust Portfolio

Follow Core First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Core First Bank & Trust with notifications on news.